" (AZN) invest $300 million in a facility in Rockville, Maryland for discovery and development of cell therapies."
Hmmm - why would a multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England open an R&D facility / partnership up the road from NWBO HQ in MA ?
The painful part is just starting to become real. I agree that the shorts will ignore everything except there own track record of success. The damn will break and then the painfully obvious will be worn and won't be ignored anymore.
This PR as some others have said is the best one we've seen.
Market Data 
Markets 
AI
